GENAZZANI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 54.437
EU - Europa 20.995
AS - Asia 10.265
SA - Sud America 703
AF - Africa 152
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 30
Totale 86.631
Nazione #
US - Stati Uniti d'America 52.849
IT - Italia 6.393
CN - Cina 5.659
SE - Svezia 2.992
BG - Bulgaria 2.278
UA - Ucraina 2.133
PL - Polonia 1.795
SG - Singapore 1.733
CA - Canada 1.553
TR - Turchia 1.287
DE - Germania 1.267
RU - Federazione Russa 908
CH - Svizzera 876
VN - Vietnam 845
FI - Finlandia 840
GB - Regno Unito 749
BR - Brasile 627
HK - Hong Kong 424
FR - Francia 310
BE - Belgio 134
IN - India 100
NL - Olanda 66
CI - Costa d'Avorio 55
AU - Australia 36
IE - Irlanda 36
BJ - Benin 28
EU - Europa 28
RO - Romania 28
ES - Italia 27
KR - Corea 25
GR - Grecia 24
AR - Argentina 22
MX - Messico 21
PK - Pakistan 21
IL - Israele 20
CZ - Repubblica Ceca 19
HU - Ungheria 19
IQ - Iraq 18
BD - Bangladesh 17
PT - Portogallo 16
DK - Danimarca 15
JP - Giappone 14
VE - Venezuela 14
NZ - Nuova Zelanda 13
CL - Cile 12
ZA - Sudafrica 12
AT - Austria 11
MA - Marocco 11
CO - Colombia 10
HR - Croazia 10
AE - Emirati Arabi Uniti 9
EC - Ecuador 9
JO - Giordania 9
NG - Nigeria 9
NP - Nepal 9
PH - Filippine 9
SN - Senegal 9
AL - Albania 8
EG - Egitto 8
ID - Indonesia 7
RS - Serbia 7
UZ - Uzbekistan 7
EE - Estonia 6
KE - Kenya 6
NO - Norvegia 6
IS - Islanda 5
LB - Libano 5
MY - Malesia 4
PE - Perù 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TH - Thailandia 4
TW - Taiwan 4
AM - Armenia 3
AZ - Azerbaigian 3
CD - Congo 3
IR - Iran 3
JM - Giamaica 3
LK - Sri Lanka 3
LT - Lituania 3
NI - Nicaragua 3
OM - Oman 3
SA - Arabia Saudita 3
TN - Tunisia 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PR - Porto Rico 2
SC - Seychelles 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
Totale 86.618
Città #
Woodbridge 8.160
Ann Arbor 5.939
Houston 5.452
Fairfield 5.347
Chandler 3.680
Milan 3.097
Jacksonville 2.853
Ashburn 2.721
Seattle 2.398
Sofia 2.277
Wilmington 2.026
Cambridge 1.868
Ottawa 1.496
Shanghai 1.453
New York 1.223
Beijing 1.142
Singapore 924
Santa Clara 915
Nanjing 903
Boardman 883
Izmir 870
Bern 862
Princeton 849
Lawrence 841
Medford 806
Des Moines 630
Jüchen 504
Dearborn 497
Hong Kong 407
Istanbul 389
Dong Ket 386
Nanchang 329
San Diego 236
Council Bluffs 233
Falls Church 212
Kunming 193
Rome 184
Shenyang 164
Boulder 160
Changsha 137
Hebei 137
Marseille 135
Brussels 132
Ogden 129
Tianjin 119
Lancaster 115
Norwalk 115
Hefei 107
Jiaxing 99
Redwood City 93
Orange 86
Frankfurt am Main 83
Los Angeles 76
Verona 75
Washington 70
Guangzhou 68
Hangzhou 66
Florence 65
Pune 65
Düsseldorf 58
Abidjan 55
Serra 48
Jinan 47
Fuzhou 45
Lanzhou 45
London 45
Edinburgh 41
São Paulo 40
Changchun 38
Indiana 38
Dallas 35
Zhengzhou 33
Detroit 29
Cotonou 28
Ningbo 28
Toronto 27
Pisa 26
Dublin 25
San Francisco 25
Phoenix 23
Quanzhou 23
Amsterdam 20
Chengdu 20
Belo Horizonte 19
Chicago 19
Munich 18
Helsinki 17
Tappahannock 17
Wuhan 17
Auburn Hills 16
Rio de Janeiro 16
Seacroft 16
Taizhou 16
Madrid 15
Curitiba 13
Stockholm 13
Boston 12
Fortaleza 12
Baghdad 11
Budapest 11
Totale 66.581
Nome #
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism 1.893
Menopause, Hormone Replacement Therapy (HRT) and Obesity 326
Optimizing quality of life through sex steroids by their effects on neurotransmitters 209
Plasma and CSF endorphin levels in primary and symptomatic headaches. 189
Plasma levels of gonadotropins, prolactin, thyroxine, and adrenal and gonadal steroids in obese prepubertal girls. 187
Dermorphin decreases plasma LH levels in human: evidence for a modulatory role of gonadal steroids. 187
Clinical and endocrinological investigations on superovulation induced in heifers by human menopausal gonadotrophin. 184
Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. 171
Plasma androgens and menstrual cycle: physiopathological correlates from adolescence to menopause. 170
The relative contributions of menopause and aging to postmenopausal reduction in intervertebral disk height 169
Secretion pattern of endogenous opioids in chronic schizophrenia. 168
Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. 167
Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. 164
Estimation of instantaneous secretory rate of luteinizing hormone in women during the menstrual cycle and in men. 164
Opioids and testicular activity in the frog, Rana esculenta. 163
Pituitary response to hypoglycemia in pituitary diseases. 162
Endogenous opioid inhibitory tone on LH secretion in normal puberty and in several pubertal disturbances. 162
The HRT misuse and osteoporosis epidemic: a possible future scenario 162
Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine. 161
Domperidone in defective and insufficient lactation. 161
Endothelium and estrogen receptors 161
Beta-endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women. 160
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells 160
Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats. 159
Cytogenetic study on 282 patients with suspected chromosomal aberration. 159
Absent B-endorphin response to clonidine in obese children. 159
Oestradiol/progesterone imbalance and the premenstrual syndrome. 158
Plasma thyrotrophin levels during pregnancy. 157
Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. 157
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women 157
Plasma opioid levels in post-traumatic chronic headache and trigeminal neuralgia: maintained response to acupuncture. 156
The association of menstrual migraine with the premenstrual syndrome. 155
Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy Villa Tuscolana, Frascati (Rome), May 8-9, 2007 155
Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. 154
Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. 154
Progressive impairment of CSF beta-EP levels in migraine sufferers. 153
Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor 153
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists. 152
Lack of beta-endorphin plasma level rise in oxytocin-induced labor. 152
Pregnancy diagnosis in cattle by a rapid and highly reliable method for progesterone determination in milk. 152
Factors associated with pain complaints in a clinical sample of postmenopausal women. 152
The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy 152
Nomifensine: diagnostic test in hyperprolactinemic states. 151
Plasma levels of luteinizing hormone, estradiol and androstenedione in sows with inadequate plasma progesterone. 151
Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome 151
Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology. 150
Adrenal and gonadal steroids in girls during sexual maturation. 150
Concomitant increase in nociceptive flexion reflex threshold and plasma opioids following transcutaneous nerve stimulation. 150
Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations. 150
Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition. 150
Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise. 150
Presence of acetylated and shortened endorphins in human fetal pituitary gland. 150
Episodic release of prolactin in women with weight loss-related amenorrhea. 150
Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats 150
Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia. 149
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women. 149
Glucocorticoids but not vasopressin or oxytocin inhibit luteinizing hormone secretion in patients with psychogenic amenorrhea. 149
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 149
Adrenal and gonadal steroids and pituitary response to LHRH in girls. II. Precocious puberty. 148
Different rebound rise in plasma prolactin during the postdopamine infusion phase in puerperal women and patients with pathological hyperprolactinemia 148
Plasma opioids in the first hours of life. 148
Expression of proopiomelanocortin-related peptides in human follicular fluid. 148
Pituitary proopiomelanocortin peptides in mental disorders. 148
Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas. 148
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel. 148
Opioid plasma levels during labour. 147
Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding. 147
Reduced cerebrospinal fluid B-endorphin levels in Rett syndrome. 147
Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study. 147
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome 147
Endorphin patterns within the headache spectrum disorders. 146
Nomifensine-induced pregnancy in a hyperprolactinemic woman. 146
Central opioid receptor activity in patients affected by puerperal, idiopathic and tumoral hyperprolactinemia. 146
Intrinsic secretory characteristics of luteinizing hormone and prolactin episodic release during pubertal development. 146
Pharmacotherapy: Benefits of menopausal hormone therapy--timing is key. 146
Hypothalamus-pituitary-adrenal axis of heroin addicts. 145
Proopiomelanocortin-related peptides and methionine enkephalin in human follicular fluid: changes during the menstrual cycle. 145
Menstrual-related mood changes in patients with oligomenorrhea. 145
Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy. 145
Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency 145
Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. 144
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists. 144
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea. 144
Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis 144
Gonadal steroid modulation of naloxone-induced LH secretion in the rat. 143
Fetal intermediate lobe is stimulated by parturition 143
Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. 142
Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women. 142
Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion. 141
Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts. 141
Met-enkephalin enhances follicle-stimulating hormone-dependent progesterone production from cultured granulosa cells. 141
Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy. 141
Abnormal concentration of maternal serum activin-A in gestational diseases. 141
Contraception in older woman. 141
The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors. 141
From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health 141
Circulating beta-endorphin levels at various stages of life: possible connections with migraine pathogenesis. 140
Local production and action of follistatin in human placenta. 140
Beta-lipotropin and beta-endorphin in physiological and surgical menopause. 139
Specific concordance index defines the physiological lag between LH and progesterone in women during the midluteal phase of the menstrual cycle. 139
Totale 17.203
Categoria #
all - tutte 214.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 214.739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.957 0 0 0 0 0 0 0 1.143 1.665 749 1.156 244
2020/20217.218 821 288 740 365 884 245 566 694 467 638 405 1.105
2021/20228.772 72 341 137 741 1.943 1.361 180 386 623 226 304 2.458
2022/20238.366 1.193 702 344 799 1.231 1.315 100 761 1.247 46 527 101
2023/202411.138 1.944 1.174 1.512 628 1.315 1.403 106 300 176 1.867 85 628
2024/20257.569 47 921 141 1.491 1.143 1.613 1.641 572 0 0 0 0
Totale 87.084